Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tobias Malte Larsen"'
Autor:
Annmarie Touborg Lassen, Jakob Lundager Forberg, Anton Pottegård, Ulf Ekelund, Mikkel Brabrand, Rune Vad, Tobias Malte Larsen, Helene Kildegaard
Publikováno v:
BMJ Open, Vol 11, Iss 12 (2021)
Objectives Emerging evidence supports that PR interval prolongation is associated with increased mortality. However, most previous studies have limited confounder control, and clinical impact in a population of acute ill patients is unknown. The aim
Externí odkaz:
https://doaj.org/article/57eee0990b6f47e8b502c4f5046bc755
Autor:
Rune Vad, Tobias Malte Larsen, Helene Kildegaard, Mikkel Brabrand, Jakob Lundager Forberg, Ulf Ekelund, Anton Pottegard, Annmarie Touborg Lassen
Publikováno v:
BMJ Open
Vad, R, Larsen, T M, Kildegaard, H, Brabrand, M, Forberg, J L, Ekelund, U, Pottegard, A & Lassen, A T 2021, ' PR interval prolongation and 1-year mortality among emergency department patients: a multicentre transnational cohort study ', BMJ Open, vol. 11, no. 12, e054238 . https://doi.org/10.1136/bmjopen-2021-054238
Vad, R, Larsen, T M, Kildegaard, H, Brabrand, M, Forberg, J L, Ekelund, U, Pottegard, A & Lassen, A T 2021, ' PR interval prolongation and 1-year mortality among emergency department patients: a multicentre transnational cohort study ', BMJ Open, vol. 11, no. 12, e054238 . https://doi.org/10.1136/bmjopen-2021-054238
Objectives Emerging evidence supports that PR interval prolongation is associated with increased mortality. However, most previous studies have limited confounder control, and clinical impact in a population of acute ill patients is unknown. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6000c4662f0af2aaed554c0203e052f3
https://pubmed.ncbi.nlm.nih.gov/34907068
https://pubmed.ncbi.nlm.nih.gov/34907068
Autor:
Liv Erngaard, Torben Lykke Sørensen, Troels Brynskov, Inger Christine Munch, Tobias Malte Larsen
Publikováno v:
Brynskov, T, Munch, I C, Larsen, T, Erngaard, L & Sørensen, T L 2020, ' Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration ', Acta Ophthalmologica, vol. 98, no. 2, pp. 132-138 . https://doi.org/10.1111/aos.14183
Brynskov, T, Munch, I C, Larsen, T M, Erngaard, L & Sørensen, T L 2020, ' Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration ', Acta Ophthalmologica, vol. 98, no. 2, pp. 132-138 . https://doi.org/10.1111/aos.14183
Brynskov, T, Munch, I C, Larsen, T M, Erngaard, L & Sørensen, T L 2020, ' Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration ', Acta Ophthalmologica, vol. 98, no. 2, pp. 132-138 . https://doi.org/10.1111/aos.14183
Purpose: To report 10-year, real-world experiences with intravitreal therapy (IVT) using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration (nAMD). Methods: Retrospective single-centre review of IVT-log 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c8af08bf8ea755273f9fedc65acb45a
https://doi.org/10.1111/aos.14183
https://doi.org/10.1111/aos.14183